Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Steven K. Seung"'
Autor:
Marka Crittenden, Brendan Curti, Walter J Urba, Roxanne Payne, Steven K Seung, Christopher B Fountain, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background A pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM). We performed a prospective
Externí odkaz:
https://doaj.org/article/72a1471a8e22419ca13b3f3faa4d22e6
Autor:
Marka Crittenden, Brendan Curti, Walter J Urba, Roxanne Payne, Steven K Seung, Christopher B Fountain, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Objectives The interaction between the immune system and tumor cells is an important feature for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) analyses are emerging technologies th
Autor:
Thien Hoang, Amber L. Watters, Marcus Couey, Hong D. Xiao, Steven K. Seung, Shu-Ching Chang, R. Bryan Bell, Eric J. Dierks, Ashish A. Patel, Rom Leidner, Kristina H. Young, Allen C. Cheng, Chi T. Viet, Marka R. Crittenden
Publikováno v:
Oral oncology. 109
In this study we determine the survival in patients with HPV-positive oropharyngeal carcinoma treated with transoral robotic surgery (TORS), neck dissection and risk-adapted adjuvant therapy.We retrospectively identified 122 patients with HPV-positiv
Autor:
Jessica Fleser, Marka R. Crittenden, Shu-Ching Chang, Walter J. Urba, Christopher B. Fountain, Lyn B Dobrunick, Steven K. Seung, Brendan D. Curti, Ian Malkasian, Kimberly Phillips, Roxanne Payne
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundA pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM). We performed a prospective r
Autor:
Laith Al-Qamachi, Hemantha K. Amarasinghe, Peter E. Andersen, Kevin Arce, Varun Arya, Tomer Avraham, Richard L. Bakst, Lauren E. Basile, Andrew D. Beckler, R. Bryan Bell, Sandeep Bhuta, Carlo B. Bifulco, Gido Bittermann, Keith E. Blackwell, Angel Blanco, Alexander M. Bobinskas, Caroline Brammer, Lawrence E. Brecht, James Brown, Chris J. Butterworth, Eric R. Carlson, Keith A. Chadwick, Srinivasa R. Chandra, Allen Cheng, Scott Claiborne, Daniel R. Clayburgh, Marka R. Crittenden, Brendan D. Curti, Derfel ap Dafydd, Roi Dagan, Camilla Dawson, Eric J. Dierks, Jasjit K. Dillon, Donita Dyalram, Sean P. Edwards, David A. Elliott, Mererid Evans, Adam P. Fagin, Carole Fakhry, Mark B. Faries, Zipei Feng, Rui P. Fernandes, Jay K. Ferrell, Bernard A. Fox, Clifton D. Fuller, G.E. Ghali, John P. Gleysteen, Kathryn A. Gold, James Good, Jennifer R. Grandis, Donna J. Graville, Neil D. Gross, Aaron Grossberg, Shan Guo, Bronwyn Hamilton, Eric K. Hansen, Heidi J. Hansen, Bruce H. Haughey, Richard E. Hayden, Joseph I. Helman, David L. Hirsch, John M. Holland, Katherine A. Hutcheson, Megan J. Hyers, Matthew Idle, James E. Jackson, Scharukh Jalisi, Newell W. Johnson, Terry M. Jones, Deepak Kademani, Joseph R. Kelley, Cyrus Kerawala, Dongsoo David Kim, Tamar A. Kotz, Hirofumi Kuno, Moni Abraham Kuriakose, Susan E. Langmore, Rom Leidner, Jamie P. Levine, Christopher Loh, Sapna Lohiya, Joshua E. Lubek, Andrew J. Lyons, Joann Marruffo, Robert E. Marx, Marco Matos, Austin Mattox, Avanti Mehrotra, James C. Melville, Marc C. Metzger, Brett A. Miles, Krzysztof J. Misiukiewicz, Abdallah S.R. Mohamed, Casian Monaco, James Murphy, Nima Nabavizadeh, Mohammed Nadershah, Thomas H. Nagel, Kate Newbold, Dimitrios Nikolarakos, Kurt Nisi, Robert A. Ord, Larry M. Over, Sara I. Pai, Andrew D. Palmer, Sat Parmar, Ashish A. Patel, Ketan Patel, JoanneM. Patterson, Daniel Petrisor, Phillip Pirgousis, Jesse R. Qualliotine, Francesco M.G. Riva, Samuel J. Rubin, Osamu Sakai, Andrew Salama, Joshua S. Schindler, Rainer Schmelzeisen, Steven K. Seung, Jonathan Shum, Felix Sim, Ryan J. Smart, John T. Stranix, Janakiraman Subramanian, Mohan Suntharalingam, Krishnakumar Thankappan, James Phillip Thomas, David Tighe, Khaled A. Tolba, Scott H. Troob, Minh Tam Truong, Ramzey Tursun, Brent B. Ward, Amber L. Watters, Mark K. Wax, Richard M. Webster, Andrew Weinberg, Hong D. Xiao, Yavuz Yildirim, Yedeh Ying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e655b459715d768ea359125419001fc9
https://doi.org/10.1016/b978-0-323-26568-3.01002-2
https://doi.org/10.1016/b978-0-323-26568-3.01002-2
Autor:
Eric J. Dierks, Ashish A. Patel, R. Bryan Bell, Rom Leidner, Megan J. Hyers, Allen C. Cheng, Steven K. Seung, Amber L. Watters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8540d981fae3a95b41140afcd0521596
https://doi.org/10.1016/b978-0-323-26568-3.00035-x
https://doi.org/10.1016/b978-0-323-26568-3.00035-x
Autor:
Michael J. Gough, Bernard A. Fox, Zeljka Jutric, Andrew D. Weinberg, Marka R. Crittenden, Rom Leidner, R. Bryan Bell, Brendan D. Curti, Steven K. Seung
Publikováno v:
Oral oncology. 66
Autor:
Rom Leidner, Steven K. Seung, Zeljka Jutric, Marka R. Crittenden, R. Bryan Bell, Michael J. Gough, Bernard A. Fox, Brendan D. Curti, Andrew D. Weinberg
Publikováno v:
Oral oncology. 61
Cytoreductive surgery is an approach to cancer treatment that aims to reduce the number of cancer cells via resection of primary tumor or metastatic deposits, in an effort to minimize a potentially immunosuppressive tumor burden, palliate symptoms, a
Autor:
William L. Redmond, Steven K. Seung, Maryclare Sarff, M.R. Crittenden, John T. Vetto, Michael J. Gough, Andrew D. Weinberg, Puiyi Pang, Hong-Ming Hu, John M. Holland
Publikováno v:
Journal of Immunotherapy. 33:798-809
The tumor recurrence from residual local or micrometastatic disease remains a problem in cancer therapy. In patients with soft tissue sarcoma and the patients with inoperable nonsmall cell lung cancer, local recurrence is common and significant morta